dapsone 5 % Topical Gel
- RxCUI
- 607295
- RxNorm name
- dapsone 5 % Topical Gel
- Display name
- dapsone 5 % Topical Gel
- Full name
- dapsone 5 % Topical Gel
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:17
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DAPSONE | DAPSONE | Alembic Pharmaceuticals Limited | 0f1301f6-884d-4fc7-a5b2-421b2375b985 | 2026-07-09 | Warnings, Adverse reactions | 607295 |
| DAPSONE | DAPSONE | Alembic Pharmaceuticals Inc. | 7249f655-1d8e-482a-889a-1e7e1a19500c | 2026-07-09 | Warnings, Adverse reactions | 607295 |
| Dapsone | DAPSONE GEL, 5% | Encube Ethicals, Inc. | 4205a1a9-c459-47bb-9538-1dd559ca71f1 | 2025-10-31 | Warnings, Adverse reactions | 607295 |
| Dapsone | DAPSONE GEL, 5% | Trupharma, LLC | 699b6157-3245-43b6-91ee-c86ea262bc83 | 2025-09-05 | Warnings, Adverse reactions | 607295 |
| Dapsone | DAPSONE | NORTHSTAR RX LLC | 91d027f1-cbc6-4066-870b-01b1ddb1f48f | 2025-07-09 | Warnings, Adverse reactions | 607295 |
| Dapsone | DAPSONE | Sun Pharmaceutical Industries, Inc. | 97e6444c-1496-4508-9434-8a2a93225e17 | 2025-07-01 | Warnings, Adverse reactions | 607295 |
| DAPSONE | DAPSONE | Aurobindo Pharma Limited | acd33f0b-8563-467a-93db-a11902331528 | 2025-05-30 | Warnings, Adverse reactions | 607295 |
| Dapsone | DAPSONE | Mayne Pharma | dc495e54-8917-42de-a9fa-1f961bd99d61 | 2024-01-31 | Warnings, Adverse reactions | 607295 |
| DAPSONE | DAPSONE | Cosette Pharmaceuticals, Inc. | bc035edf-50d0-47ba-9b60-fe394ab3c32f | 2023-05-08 | Warnings, Adverse reactions | 607295 |
| Dapsone | DAPSONE | Amneal Pharmaceuticals LLC | f3e33970-ac11-4bb6-9f39-6f58d86fdefb | 2020-05-24 | Warnings, Adverse reactions | 607295 |
| DAPSONE | DAPSONE | Pacific Pharma, Inc. | 8dbe1a41-6d9d-414f-aa9c-09bd95857e2a | 2018-09-30 | Warnings, Adverse reactions | 607295 |
| ACZONE | DAPSONE | Allergan, Inc. | b7d605cf-bf84-461b-939b-1f773a4cba65 | 2018-05-28 | Warnings, Adverse reactions | 607295 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b7d605cf-bf84-461b-939b-1f773a4cba65 | dapsone 0.05 MG/MG Topical Gel | SCD | 16 | These highlights do not include all the information needed to use ACZONE ® Gel, 5% safely and effectively. See full prescribing information for ACZONE ® Gel, 5%. ACZONE ® (dapsone) Gel, 5%, for topical use Initial U.S. Approval: 1955 | 20180528 |
| b7d605cf-bf84-461b-939b-1f773a4cba65 | dapsone 5 % Topical Gel | PSN | 16 | These highlights do not include all the information needed to use ACZONE ® Gel, 5% safely and effectively. See full prescribing information for ACZONE ® Gel, 5%. ACZONE ® (dapsone) Gel, 5%, for topical use Initial U.S. Approval: 1955 | 20180528 |
| b7d605cf-bf84-461b-939b-1f773a4cba65 | dapsone 5 % Topical Gel | SY | 16 | These highlights do not include all the information needed to use ACZONE ® Gel, 5% safely and effectively. See full prescribing information for ACZONE ® Gel, 5%. ACZONE ® (dapsone) Gel, 5%, for topical use Initial U.S. Approval: 1955 | 20180528 |
| f3e33970-ac11-4bb6-9f39-6f58d86fdefb | dapsone 0.05 MG/MG Topical Gel | SCD | 7 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20200524 |
| f3e33970-ac11-4bb6-9f39-6f58d86fdefb | dapsone 5 % Topical Gel | SY | 7 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20200524 |
| f3e33970-ac11-4bb6-9f39-6f58d86fdefb | dapsone 5 % Topical Gel | PSN | 7 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20200524 |
| 97e6444c-1496-4508-9434-8a2a93225e17 | dapsone 5 % Topical Gel | SY | 6 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20250701 |
| 97e6444c-1496-4508-9434-8a2a93225e17 | dapsone 0.05 MG/MG Topical Gel | SCD | 6 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20250701 |
| 97e6444c-1496-4508-9434-8a2a93225e17 | dapsone 5 % Topical Gel | PSN | 6 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20250701 |
| 8dbe1a41-6d9d-414f-aa9c-09bd95857e2a | dapsone 5 % Topical Gel | PSN | 6 | These highlights do not include all the information needed to use dapsone gel, 5% safely and effectively. See full prescribing information for dapsone gel, 5%. Dapsone gel, 5%, for topical use Initial U.S. Approval: 1955 | 20180930 |
| 8dbe1a41-6d9d-414f-aa9c-09bd95857e2a | dapsone 0.05 MG/MG Topical Gel | SCD | 6 | These highlights do not include all the information needed to use dapsone gel, 5% safely and effectively. See full prescribing information for dapsone gel, 5%. Dapsone gel, 5%, for topical use Initial U.S. Approval: 1955 | 20180930 |
| 8dbe1a41-6d9d-414f-aa9c-09bd95857e2a | dapsone 5 % Topical Gel | SY | 6 | These highlights do not include all the information needed to use dapsone gel, 5% safely and effectively. See full prescribing information for dapsone gel, 5%. Dapsone gel, 5%, for topical use Initial U.S. Approval: 1955 | 20180930 |
| 4205a1a9-c459-47bb-9538-1dd559ca71f1 | dapsone 5 % Topical Gel | SY | 5 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20251031 |
| 4205a1a9-c459-47bb-9538-1dd559ca71f1 | dapsone 0.05 MG/MG Topical Gel | SCD | 5 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20251031 |
| 4205a1a9-c459-47bb-9538-1dd559ca71f1 | dapsone 5 % Topical Gel | PSN | 5 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20251031 |
| 699b6157-3245-43b6-91ee-c86ea262bc83 | dapsone 5 % Topical Gel | SY | 3 | These highlights do not include all the information needed to use Dapsone Gel, 5% safely and effectively. See full prescribing information for Dapsone Gel, 5%. Dapsone Gel, 5%, for topical use Initial U.S. Approval: 1955 | 20250905 |
| 699b6157-3245-43b6-91ee-c86ea262bc83 | dapsone 5 % Topical Gel | PSN | 3 | These highlights do not include all the information needed to use Dapsone Gel, 5% safely and effectively. See full prescribing information for Dapsone Gel, 5%. Dapsone Gel, 5%, for topical use Initial U.S. Approval: 1955 | 20250905 |
| 699b6157-3245-43b6-91ee-c86ea262bc83 | dapsone 0.05 MG/MG Topical Gel | SCD | 3 | These highlights do not include all the information needed to use Dapsone Gel, 5% safely and effectively. See full prescribing information for Dapsone Gel, 5%. Dapsone Gel, 5%, for topical use Initial U.S. Approval: 1955 | 20250905 |
| 91d027f1-cbc6-4066-870b-01b1ddb1f48f | dapsone 5 % Topical Gel | PSN | 2 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20250709 |
| 91d027f1-cbc6-4066-870b-01b1ddb1f48f | dapsone 5 % Topical Gel | SY | 2 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20250709 |
| 91d027f1-cbc6-4066-870b-01b1ddb1f48f | dapsone 0.05 MG/MG Topical Gel | SCD | 2 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20250709 |
| acd33f0b-8563-467a-93db-a11902331528 | dapsone 5 % Topical Gel | PSN | 2 | These highlights do not include all the information needed to use DAPSONE GEL, 5% safely and effectively. See full prescribing information for DAPSONE GEL, 5%. DAPSONE gel, 5%, for topical use Initial U.S. Approval: 1955 | 20250530 |
| acd33f0b-8563-467a-93db-a11902331528 | dapsone 5 % Topical Gel | SY | 2 | These highlights do not include all the information needed to use DAPSONE GEL, 5% safely and effectively. See full prescribing information for DAPSONE GEL, 5%. DAPSONE gel, 5%, for topical use Initial U.S. Approval: 1955 | 20250530 |
| acd33f0b-8563-467a-93db-a11902331528 | dapsone 0.05 MG/MG Topical Gel | SCD | 2 | These highlights do not include all the information needed to use DAPSONE GEL, 5% safely and effectively. See full prescribing information for DAPSONE GEL, 5%. DAPSONE gel, 5%, for topical use Initial U.S. Approval: 1955 | 20250530 |
| dc495e54-8917-42de-a9fa-1f961bd99d61 | dapsone 0.05 MG/MG Topical Gel | SCD | 1 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20240131 |
| dc495e54-8917-42de-a9fa-1f961bd99d61 | dapsone 5 % Topical Gel | PSN | 1 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20240131 |
| dc495e54-8917-42de-a9fa-1f961bd99d61 | dapsone 5 % Topical Gel | SY | 1 | These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 1955 | 20240131 |
| bc035edf-50d0-47ba-9b60-fe394ab3c32f | dapsone 0.05 MG/MG Topical Gel | SCD | 1 | These highlights do not include all the information needed to use DAPSONE GEL, 5% safely and effectively. See full prescribing information for DAPSONE GEL, 5%. DAPSONE gel, 5%, for topical use only Initial U.S. Approval: 1955 | 20230508 |
| bc035edf-50d0-47ba-9b60-fe394ab3c32f | dapsone 5 % Topical Gel | PSN | 1 | These highlights do not include all the information needed to use DAPSONE GEL, 5% safely and effectively. See full prescribing information for DAPSONE GEL, 5%. DAPSONE gel, 5%, for topical use only Initial U.S. Approval: 1955 | 20230508 |
| bc035edf-50d0-47ba-9b60-fe394ab3c32f | dapsone 5 % Topical Gel | SY | 1 | These highlights do not include all the information needed to use DAPSONE GEL, 5% safely and effectively. See full prescribing information for DAPSONE GEL, 5%. DAPSONE gel, 5%, for topical use only Initial U.S. Approval: 1955 | 20230508 |